Published with this product (8)
2024American Journal of Physiology-Heart and Circulatory Physiology
Innervation of Adipocytes is Limited in Mouse Perivascular Adipose Tissue
Marie Hanscom, Wilmarie Morales-Soto, Stephanie W Watts, William F. Jackson, and Brian D. Gulbransen
doi:10.1152/ajpheart.00041.20242023Nature Communications 14, 5165
Dalia Halawani, Yiqun Wang, Aarthi Ramakrishnan, Molly Estill, Xijing He, Li Shen, Roland H. Friedel, and Hongyan Zou
doi:10.1038/s41467-023-40816-72023Research Square
Diego N. Messina, Emanuel D. Peralta, and Cristian G. Acosta
doi:10.21203/rs.3.rs-3433175/v12022Scientific Reports, 12:20589
Yuuki Shirai, Junko Okano, Takahiko Nakagawa, Miwako Katagi, Yuki Nakae, Atsuhiro Arakawa, Shinya Koshinuma, Gaku Yamamoto, and Hideto Kojima
doi:10.1038/s41598-022-24957-12019Journal of Neurochemistry
Sergio Benitez, Alicia Seltzer, Diego Messina, Mabel Foscolo, Sean Patterson, Christian Acosta
doi:10.1111/jnc.14848
Description
PGP9.5 is a soluble cytoplasmic protein with a molecular weight of approximately 25,000 kD. It is present in neurons and in cells of the diffuse neuroendocrine system. PGP9.5 functions as a tissue-specific ubiquitin carboxyl terminal hydrolase isoenzyme. This enzyme is also known as UCH-L1. Because of its abundance in nerves, it has been widely used as a marker for peripheral nerve fibers.
It was also discovered as a gene mutated in some rare famial forms of Parkinson's disease. Interestingly a common allelic variant of UCHL1, the S18Y polymorphism is actually protective against Parkinson's disease. It is also a marker for cells of the diffuse neuroendocrine system and their tumors.



Related products
- beta-Lipotropin
- CCK-8 (Cholecystokinin Octapeptide)
- CGRP
- FMRFamide
- Leu-Enkephalin
- Met-Enkephalin
- Neurokinin-1 (NK 1) Receptor
- Neurokinin-3 (NK 3) Receptor
- Neuropeptide FF1 Receptor
- Neuropeptide FF2 Receptor
- Neuropeptide Q3/NPQ3
- Neurotensin
For research use only. Not for diagnostic or clinical use.